CharlesEDavisMD
Infectious Disease • Baltimore, MDAssociate Professor, Medicine, University of Maryland School of Medicine
Are you Dr. Davis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-706-4608Fax+1 410-706-3243
Summary
- Dr. Charles Davis, MD is an infectious disease specialist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland and Texas. He is affiliated with University of Maryland Medical Center Midtown Campus and Veterans Affairs Maryland Health Care System-Baltimore Division.
Education & Training
San Antonio Uniformed Services Health Education ConsortiumFellowship, Infectious Disease, 1981 - 1983- San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 1978 - 1981
Virginia Commonwealth University School of MedicineClass of 1978
Certifications & Licensure
MD State Medical License 1998 - 2020
TX State Medical License 1983 - 2015
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine Start of enrollment: 2004 Mar 01
- Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study Start of enrollment: 2005 Dec 01
- FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir Start of enrollment: 2013 Apr 25
Publications & Presentations
PubMed
- 1 citationsVariability of CD4+ Cell Counts in HIV-1-Uninfected Volunteers Who Are Eligible for a Phase I HIV Vaccine Study.Kristen A Stafford, Bryan T. Mayer, William Fulp, Joel Chua, Charles E. L. B. Davis
Journal of Acquired Immune Deficiency Syndromes. 2020-05-01 - 8 citationsImpact of antiretroviral regimen on renal transplant outcomes in HIV-infected recipients.T. Sparkes, Wana Manitpisitkul, B. Masters, Stephen T. Bartlett, Charles E. L. B. Davis
Transplant Infectious Disease. 2018-12-01 - 15 citationsMonotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized mice.Alonso Heredia, Said Hassounah, Sandra Medina-Moreno, Juan C. Zapata, Nhut Le
The Journal of Antimicrobial Chemotherapy. 2017-09-01
